Theriva Biologics Inc (TOVX)
1.28
+0.02
(+1.59%)
USD |
NYAM |
Nov 21, 16:00
1.28
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2010 | 0.00 |
| September 30, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 0.00 |
| December 31, 2009 | 0.00 |
| September 30, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| September 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | 0.00 |
| December 31, 2007 | 0.0753 |
| September 30, 2007 | 0.1323 |
| June 30, 2007 | 0.0607 |
| March 31, 2007 | 0.0574 |
| December 31, 2006 | 0.00 |
| September 30, 2006 | 0.00 |
| June 30, 2006 | 0.00 |
| March 31, 2006 | 0.00 |
| March 31, 2003 | -0.708 |
| December 31, 2002 | -0.7474 |
| September 30, 2002 | -0.832 |
| June 30, 2002 | -0.8772 |
| March 31, 2002 | -0.9106 |
| Date | Value |
|---|---|
| December 31, 2001 | -0.9905 |
| September 30, 2001 | -0.9079 |
| June 30, 2001 | -0.708 |
| March 31, 2001 | -1.043 |
| December 31, 2000 | -4.834 |
| September 30, 2000 | -2.879 |
| June 30, 2000 | -9.942 |
| March 31, 2000 | 0.9041 |
| December 31, 1999 | 2.980 |
| September 30, 1999 | -0.1875 |
| June 30, 1999 | -0.8824 |
| March 31, 1999 | -3.20 |
| December 31, 1998 | 1.571 |
| September 30, 1998 | 0.3125 |
| June 30, 1998 | 0.00 |
| March 31, 1998 | -0.2432 |
| December 31, 1997 | -0.7273 |
| September 30, 1997 | -1.125 |
| June 30, 1997 | 0.00 |
| March 31, 1997 | 0.00 |
| December 31, 1996 | 0.00 |
| September 30, 1996 | 0.00 |
| June 30, 1996 | 0.00 |
| March 31, 1996 | 0.00 |
| December 31, 1995 | 0.1111 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Merck & Co Inc | 0.8568 |
| Pro-Dex Inc | 0.4367 |
| BioCardia Inc | -- |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 40.11M |
| Total Liabilities (Quarterly) | 15.47M |
| Shareholders Equity (Quarterly) | 24.64M |